Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Caffeine intake during pregnancy and lactation can cause skin lesions in mother rats and their babies, not linked to cortisol levels.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Platelet-rich plasma injections are an effective treatment for hair loss with minimal side effects.

Melatonin applied to the scalp helps increase hair density in people with early hair loss.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

Melatonin applied to the scalp helps treat early-stage hair loss in men and women.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Sex hormones affect dog skin conditions, but more data is needed.

Older age, obesity, hirsutism, and having children increase metabolic risk in women with PCOS.

PCOS increases the risk of heart disease and type 2 diabetes in women.

SRD5A2 enzyme expression varies in benign prostates and can be influenced by inflammation, affecting treatment options.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Metformin and clomiphene citrate together improve pregnancy chances and reduce miscarriages in women with PCOS.

The test product significantly improved hair growth and reduced hair fall without causing skin issues.

Small injections of dutasteride improved hair thickness in men with hair loss without major side effects.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

17β-estradiol can reduce inflammation in the skin.

The FDA did not approve a testosterone drug because of safety concerns.

The FDA rejected a testosterone drug again due to safety concerns.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.